Fifth Amended and Restated Credit Agreement and GuarantyCredit Agreement • May 15th, 2025 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
CREDIT AGREEMENT AND GUARANTY dated as of APRIL 25, 2025 among EXAGEN INC., as the Borrower, THE GUARANTORS FROM TIME TO TIME PARTY HERETO, as Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO, as Lenders, AND PERCEPTIVE CREDIT HOLDINGS IV, LP,...Credit Agreement • April 28th, 2025 • Exagen Inc. • Services-medical laboratories • New York
CREDIT AGREEMENT AND GUARANTY, dated as of April 25, 2025 (as the same may be amended, restated, amended and restated, modified, or supplemented from time to time, this “Agreement”), among EXAGEN INC., a Delaware corporation (the “Borrower”), certain Guarantors from time to time parties hereto, the lenders from time to time party hereto (each, as a “Lender” and collectively, the “Lenders”) and PERCEPTIVE CREDIT HOLDINGS IV, LP, a Delaware limited partnership (“Perceptive”), as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”).
Fourth Amended and Restated Credit Agreement and GuarantyCredit Agreement • February 28th, 2025 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
Third Amended and Restated Credit Agreement and GuarantyCredit Agreement • December 26th, 2024 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
Credit Agreement and Guaranty dated as of May 2, 2024 among SOPHiA GENETICS SA as Borrower, The Guarantors From Time To Time Party Hereto, as Guarantors, The Lenders From Time To Time Party Hereto, as Lenders, and Perceptive Credit Holdings IV, LP, as...Credit Agreement • May 7th, 2024 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances) • New York
Credit Agreement and Guaranty, dated as of May 2, 2024 (this “Agreement”), among SOPHiA GENETICS SA, a publicly listed stock corporation (société anonyme/Aktiengesellschaft) incorporated, organized and existing under the laws of Switzerland, registered with the commercial register of the Canton of Vaud under company number CHE-184.818.745 with registered address at Zone Artisanale La Pièce 12, 1180 Rolle/VD (“Borrower”), certain Guarantors from time to time parties hereto, the lenders from time to time party hereto (each, as a “Lender” and collectively, the “Lenders”) and Perceptive Credit Holdings IV, LP, a Delaware limited partnership (“Perceptive”), as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”).
CREDIT AGREEMENT AND GUARANTY DATED AS OF DECEMBER 30, 2020 AMONG ISOPLEXIS CORPORATION, AS BORROWER, THE GUARANTORS FROM TIME TO TIME PARTY HERETO, AS GUARANTORS, THE LENDERS FROM TIME TO TIME PARTY HERETO, AS LENDERS, AND PERCEPTIVE CREDIT HOLDINGS...Credit Agreement • July 20th, 2021 • IsoPlexis Corp • Laboratory analytical instruments • New York
CREDIT AGREEMENT AND GUARANTY, dated as of December 30, 2020 (this “Agreement”), among ISOPLEXIS CORPORATION, a Delaware corporation (“Borrower”), certain Guarantors from time to time parties hereto, the lenders from time to time party hereto (each, as a “Lender” and collectively, the “Lenders”), and PERCEPTIVE CREDIT HOLDINGS III, LP, a Delaware limited partnership (“Perceptive”), as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”).
Credit Agreement and Guaranty Dated as of February 10, 2020 among Agile Therapeutics, Inc., as the Borrower, The Guarantors from Time to Time Party hereto, as Guarantors The Lenders from Time to Time Party hereto, as Lenders and Perceptive Credit...Credit Agreement • February 12th, 2020 • Agile Therapeutics Inc • Pharmaceutical preparations • New York